Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders (English)
- New search for: Imai, Y.
- New search for: Tamura, S.
- New search for: Tanaka, H.
- New search for: Hiramatsu, N.
- New search for: Kiso, S.
- New search for: Doi, Y.
- New search for: Inada, M.
- New search for: Nagase, T.
- New search for: Kitada, T.
- New search for: Imanaka, K.
- New search for: Fukuda, K.
- New search for: Takehara, T.
- New search for: Kasahara, A.
- New search for: Hayashi, N.
- New search for: Imai, Y.
- New search for: Tamura, S.
- New search for: Tanaka, H.
- New search for: Hiramatsu, N.
- New search for: Kiso, S.
- New search for: Doi, Y.
- New search for: Inada, M.
- New search for: Nagase, T.
- New search for: Kitada, T.
- New search for: Imanaka, K.
- New search for: Fukuda, K.
- New search for: Takehara, T.
- New search for: Kasahara, A.
- New search for: Hayashi, N.
In:
Journal of Viral Hepatitis
;
17
, 3
;
185-191
;
2010
- Article (Journal) / Electronic Resource
-
Title:Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders
-
Contributors:Imai, Y. ( author ) / Tamura, S. ( author ) / Tanaka, H. ( author ) / Hiramatsu, N. ( author ) / Kiso, S. ( author ) / Doi, Y. ( author ) / Inada, M. ( author ) / Nagase, T. ( author ) / Kitada, T. ( author ) / Imanaka, K. ( author )
-
Published in:Journal of Viral Hepatitis ; 17, 3 ; 185-191
-
Publisher:
- New search for: Blackwell Publishing Ltd
-
Publication date:2010-03-01
-
Size:7 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 17, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 153
-
Recent advances in Hepatitis E VirusMeng, X. J. et al. | 2010
- 162
-
Hepatitis D outbreak among children in a hepatitis B hyper‐endemic settlement in GreenlandBørresen, M. L. / Olsen, O. R. / Ladefoged, K. / McMahon, B. J. / Hjuler, T. / Panum, I. / Simonetti, J. / Jones, C. / Krarup, H. / Koch, A. et al. | 2010
- 171
-
Low efficacy of entecavir therapy in adefovir‐refractory hepatitis B patients with prior lamivudine resistanceCho, S. W. / Koh, K. H. / Cheong, J. Y. / Lee, M. H. / Hong, S. P. / Yoo, W. D. / Kim, S.‐O. et al. | 2010
- 178
-
Combination of Lamivudine and adefovir therapy in HBeAg‐positive chronic hepatitis B patients with poor response to adefovir monotherapyWang, L.‐C. / Chen, E.‐Q. / Cao, J. / Liu, L. / Wang, J.‐R. / Lei, B.‐J. / Tang, H. et al. | 2010
- 185
-
Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological respondersImai, Y. / Tamura, S. / Tanaka, H. / Hiramatsu, N. / Kiso, S. / Doi, Y. / Inada, M. / Nagase, T. / Kitada, T. / Imanaka, K. et al. | 2010
- 192
-
Genetic variation in CLDN1 and susceptibility to hepatitis C virus infectionBekker, V. / Chanock, S. J. / Yeager, M. / Hutchinson, A. A. / Von Hahn, T. / Chen, S. / Xiao, N. / Dotrang, M. / Brown, M. / Busch, M. P. et al. | 2010
- 201
-
Early treatment improves outcomes in acute hepatitis C virus infection: a meta‐analysisCorey, K. E. / Mendez‐Navarro, J. / Gorospe, E. C. / Zheng, H. / Chung, R. T. et al. | 2010
- 208
-
Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy*Yuan, H. J. / Jain, M. / Snow, K. K. / Gale Jr, M. / Lee, W. M. / the HALT‐C Trial Group et al. | 2010
- 217
-
Effect of ribavirin on the frequency of RNase L cleavage sites within the hepatitis C viral genomeMihm, U. / Hofmann, W. P. / Welsch, C. / Polta, A. / Lengauer, T. / Zeuzem, S. / Sarrazin, C. / Herrmann, E. et al. | 2010
- 222
-
T‐helper cells and liver fibrosis in hepatitis C virus‐monoinfected patientsRashkin, S. / Rouster, S. / Goodman, Z. D. / Sherman, K. E. et al. | 2010
- 227
-
Does fluvastatin favour HCV replication in vivo? A pilot study on HIV–HCV co‐infected patientsBader, T. et al. | 2010
- 228
-
In vivo effects of fluvastatin on HCV replication in HIV‐1 coinfected subjectsMilazzo, L. / Antinori, S. et al. | 2010